Literature DB >> 16617413

Design of gelatin nanoparticles as swelling controlled delivery system for chloroquine phosphate.

A K Bajpai1, Jyoti Choubey.   

Abstract

Gelatin nanoparticles were prepared by a single W/O emulsion technique and characterized by infrared (IR) spectra, scanning electron microscopy (SEM) and particle size analysis. The prepared nanoparticles were loaded with chloroquine phosphate (CP), a well known antimalarial drug, and the release dynamics of entrapped drug was investigated as a function of various experimental factors such as percent loading of the drug, chemical architecture of the nanocarriers, and pH, temperature, ionic strength and nature of the release medium. The nanoparticles were also studied for their water sorption capacity by optical microscopic method taking advantage of the aggregation of nanoparticles. The drug release processes was analyzed kinetically using Ficks power law and a correlation was established between the quantity of released drug and swelling of the nanoparticles.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16617413     DOI: 10.1007/s10856-006-8235-9

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  23 in total

Review 1.  Environment-sensitive hydrogels for drug delivery.

Authors:  Y Qiu; K Park
Journal:  Adv Drug Deliv Rev       Date:  2001-12-31       Impact factor: 15.470

2.  In vivo biocompatibility of gelatin-based hydrogels and interpenetrating networks.

Authors:  Kelly R Stevens; Nicole J Einerson; Jeanine A Burmania; Weiyuan John Kao
Journal:  J Biomater Sci Polym Ed       Date:  2002       Impact factor: 3.517

Review 3.  Recent developments of collagen-based materials for medical applications and drug delivery systems.

Authors:  K P Rao
Journal:  J Biomater Sci Polym Ed       Date:  1995       Impact factor: 3.517

4.  Malaria deaths following inappropriate malaria chemoprophylaxis--United States, 2001.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2001-07-20       Impact factor: 17.586

5.  Mucoadhesion of polystyrene nanoparticles having surface hydrophilic polymeric chains in the gastrointestinal tract.

Authors:  S Sakuma; R Sudo; N Suzuki; H Kikuchi; M Akashi; M Hayashi
Journal:  Int J Pharm       Date:  1999-01-25       Impact factor: 5.875

Review 6.  Nanoparticles in cancer therapy and diagnosis.

Authors:  Irène Brigger; Catherine Dubernet; Patrick Couvreur
Journal:  Adv Drug Deliv Rev       Date:  2002-09-13       Impact factor: 15.470

7.  Gelatin nanoparticles produced by a simple W/O emulsion as delivery system for methotrexate.

Authors:  Maria Grazia Cascone; Luigi Lazzeri; Claudia Carmignani; Zhouhai Zhu
Journal:  J Mater Sci Mater Med       Date:  2002-05       Impact factor: 3.896

8.  Bioadhesive polymers as platforms for oral controlled drug delivery II: synthesis and evaluation of some swelling, water-insoluble bioadhesive polymers.

Authors:  H S Ch'ng; H Park; P Kelly; J R Robinson
Journal:  J Pharm Sci       Date:  1985-04       Impact factor: 3.534

9.  Effects of the preparation methods of hydroxypropyl methylcellulose/polyacrylic acid blended films on drug release.

Authors:  Li-Fang Wang; W B Chen; Tzu-Yi Chen; Shui Chun Lu
Journal:  J Biomater Sci Polym Ed       Date:  2003       Impact factor: 3.517

10.  Anticancer gelatin microspheres with multiple functions.

Authors:  C H Yan; X W Li; X L Chen; D Q Wang; D C Zhong; T Z Tan; H Kitano
Journal:  Biomaterials       Date:  1991-09       Impact factor: 12.479

View more
  13 in total

1.  Producing gelatin nanoparticles as delivery system for bovine serum albumin.

Authors:  Bahareh Azimi; Parviz Nourpanah; Mohammad Rabiee; Shahram Arbab
Journal:  Iran Biomed J       Date:  2014

Review 2.  Biopolymeric nanoparticles.

Authors:  Sushmitha Sundar; Joydip Kundu; Subhas C Kundu
Journal:  Sci Technol Adv Mater       Date:  2010-02-26       Impact factor: 8.090

3.  Synthesis and characterization of gelatin nanoparticles using CDI/NHS as a non-toxic cross-linking system.

Authors:  Nader Taheri Qazvini; Sahar Zinatloo
Journal:  J Mater Sci Mater Med       Date:  2010-11-04       Impact factor: 3.896

Review 4.  Nanomedicine strategies to overcome the pathophysiological barriers of pancreatic cancer.

Authors:  Pavan P Adiseshaiah; Rachael M Crist; Sara S Hook; Scott E McNeil
Journal:  Nat Rev Clin Oncol       Date:  2016-08-17       Impact factor: 66.675

5.  An in vitro release study of 5-fluoro-uracil (5-FU) from swellable poly-(2-hydroxyethyl methacrylate) (PHEMA) nanoparticles.

Authors:  Raje Chouhan; A K Bajpai
Journal:  J Mater Sci Mater Med       Date:  2009-01-10       Impact factor: 3.896

Review 6.  Recent trends in protein and peptide-based biomaterials for advanced drug delivery.

Authors:  Anastasia Varanko; Soumen Saha; Ashutosh Chilkoti
Journal:  Adv Drug Deliv Rev       Date:  2020-08-29       Impact factor: 15.470

7.  Basics and recent advances in peptide and protein drug delivery.

Authors:  Benjamin J Bruno; Geoffrey D Miller; Carol S Lim
Journal:  Ther Deliv       Date:  2013-11

8.  Improved bioavailability and pharmacokinetics of tea polyphenols by encapsulation into gelatin nanoparticles.

Authors:  Karikalan Kulandaivelu; Abul Kalam Azad Mandal
Journal:  IET Nanobiotechnol       Date:  2017-06       Impact factor: 1.847

9.  Synthesis of magnetic molecularly imprinted polymers with excellent biocompatibility for the selective separation and inhibition of testosterone in prostate cancer cells.

Authors:  Xiaoshuang Tang; Feng Li; Jing Jia; Chao Yang; Wei Liu; Ben Jin; Xinyang Wang; Ruixia Gao; Dalin He; Peng Guo
Journal:  Int J Nanomedicine       Date:  2017-04-12

10.  Preparation of Polyurethane/Pluronic F127 Nanofibers Containing Peppermint Extract Loaded Gelatin Nanoparticles for Diabetic Wounds Healing: Characterization, In Vitro, and In Vivo Studies.

Authors:  Arash Almasian; Farhood Najafi; Mahdieh Eftekhari; Mohammad Reza Shams Ardekani; Mohammad Sharifzadeh; Mahnaz Khanavi
Journal:  Evid Based Complement Alternat Med       Date:  2021-05-15       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.